These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5335879)

  • 1. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879
    [No Abstract]   [Full Text] [Related]  

  • 2. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR
    Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments].
    Puntoni U
    Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G; Agnetti V; Mura F; Granieri E
    Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects and drug therapy of Parkinson's syndrome].
    Mumenthaler M
    Schweiz Med Wochenschr; 1966 Apr; 96(15):479-84. PubMed ID: 4862148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticholinergic treatment of Parkinson's disease (author's transl)].
    Ascher PW
    Wien Klin Wochenschr; 1976 Oct; 88(19):641-6. PubMed ID: 790774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiological trials with MIF-I in Parkinson's disease (author's transl)].
    Gonce M; Barbeau A
    Rev Neurol (Paris); 1978 Feb; 134(2):141-9. PubMed ID: 29330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind evaluation of lysivane in the treatment of Parkinson's disease.
    Strang RR
    Br J Clin Pract; 1966 May; 20(5):249-51. PubMed ID: 5326485
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of L-DOPA in the therapy of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G
    Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amantadine treatment in Parkinson's disease].
    Boman K; Kivalo E; Porras J
    Nord Med; 1970 Nov; 84(48):1518-20. PubMed ID: 4922228
    [No Abstract]   [Full Text] [Related]  

  • 19. [MIF (melanocyte-stimulating hormone release-inhibiting factor) and Parkinson's disease].
    Carolei A; Meco G; Casacchia M; Agnoli A
    Acta Neurol (Napoli); 1976; 31(4):475-8. PubMed ID: 16441
    [No Abstract]   [Full Text] [Related]  

  • 20. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.